Previous Page  3 / 5 Next Page
Information
Show Menu
Previous Page 3 / 5 Next Page
Page Background

Current Research: Integrative Medicine

Page 7

CAM Therapies 2017

Notes:

September 18-19, 2017 Charlotte, USA

5

th

International Meeting on

Complementary and Alternative Medicine & Therapies

Kristy Appelhans

Herbalife Nutrition, USA

Clinical significance of post-market surveillance for dietary supplements: A possible

framework for enhanced patient safety

U

se of dietary supplements is very common amongst providers working in integrative, complementary, and/or

alternative health care settings and the retail sale of a broad array of dietary supplements has allowed these

substances to be easily accessed by the consumer population. In fact, recent studies have stated that at least 70%

of US consumers incorporate some form of dietary supplement use into their routine nutrition/health regimen.

Therefore, it is critical to consistently and objectively review the safety of these supplements in order to properly

evaluate their use in patient wellness protocols. Unfortunately, pre-market safety data is sporadic at best beyond

traditional use knowledge for individual novel ingredients (i.e. not including those recognized as food ingredients

with well-established safety records from long-standing use in the food supply) and combined substance use data

(e.g. multi-ingredient formulations) is even less commonly established. While the body of pre-market safety

evidence is growing significantly for novel supplement ingredients and combinations, post-market surveillance

remains an important tool for evaluating the use of these substances in the population at large, which often cannot

be properly demonstrated in controlled clinical study populations. This review will present various methods

for evaluating dietary supplement safety in the post-market environment and identify potential ways in which

clinicians may use this information and assist with the broader assessment of populations using these substances

in the interest of patient safety.

Biography

KristyAppelhans has completed her Bachelor of Science in Clinical Nutrition in 2003, Doctoral degree in Naturopathic Medicine in 2007, and Masters of Science

in Regulatory Affairs in 2016. She oversees Herbalife Nutrition’s Global Post-Market Safety Surveillance department and operates a private naturopathic medical

practice. She has a broad scope of expertise related to the technical, functional, and clinical aspects of consumer safety. She has been the lead author for more than

14 peer-reviewed articles, co-authored a global industry guidance document for the collection of adverse events, and recently co-authored a book chapter on the

technical and functional aspects of adverse event collection and reporting.

kristyr@herbalife.com